Top 10 Small Cap Stocks with Highest Upside: PZG, SA, XRA, AVNR, AUMN, CKXE, ANO, XNY, PCYC, ALTH

Below are the top 10 Small Cap stocks with highest upside potential, based on the difference between current price and Wall Street analysts' average target price.

Paramount Gold and Silver Corp. (AMEX:PZG) has the 1st highest upside potential in this segment of the market. Its upside is 242.0%. Its consensus target price is $11.39 based on the average of all estimates.

Seabridge Gold, Inc. (USA) (AMEX:SA) has the 2nd highest upside potential in this segment of the market. Its upside is 196.0%. Its consensus target price is $84.99 based on the average of all estimates.

Exeter Resource Corp. (AMEX:XRA) has the 3rd highest upside potential in this segment of the market. Its upside is 193.3%. Its consensus target price is $14.87 based on the average of all estimates.

AVANIR Pharmaceuticals (NASDAQ:AVNR) has the 4th highest upside potential in this segment of the market. Its upside is 192.0%. Its consensus target price is $12.00 based on the average of all estimates.

Golden Minerals Co (AMEX:AUMN) has the 5th highest upside potential in this segment of the market. Its upside is 163.0%. Its consensus target price is $55.09 based on the average of all estimates.

CKX Inc. (NASDAQ:CKXE) has the 6th highest upside potential in this segment of the market. Its upside is 144.6%. Its consensus target price is $8.00 based on the average of all estimates.

Anooraq Resources Corporation (USA) (AMEX:ANO) has the 7th highest upside potential in this segment of the market. Its upside is 130.9%. Its consensus target price is $3.51 based on the average of all estimates.

China Xiniya Fashion Ltd (NYSE:XNY) has the 8th highest upside potential in this segment of the market. Its upside is 121.7%. Its consensus target price is $13.50 based on the average of all estimates.

Pharmacyclics, Inc. (NASDAQ:PCYC) has the 9th highest upside potential in this segment of the market. Its upside is 120.5%. Its consensus target price is $11.60 based on the average of all estimates.

Allos Therapeutics, Inc. (NASDAQ:ALTH) has the 10th highest upside potential in this segment of the market. Its upside is 117.2%. Its consensus target price is $7.17 based on the average of all estimates.